Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
Microcephaly-seizures-intellectual disability-heart disease syndrome is characterized by intellectual deficit, a cardiac anomaly, micropenis, hypothyroidism, epileptic seizures, and skeletal anomalies. It has been described in two males.
Biomarker and diagnostic research for microcephaly-seizures-intellectual disability-heart disease syndrome has been reported in the published literature.
Estimated prevalence: <1 in 1,000,000 (VERY_RARE).
No clinical trials have been registered for microcephaly-seizures-intellectual disability-heart disease syndrome.
207 publications have been identified in PubMed for microcephaly-seizures-intellectual disability-heart disease syndrome. Kisho has analyzed 136 by research type. Research spans Review / Meta-Analysis (65%), Case Report / Case Series (10%), and Basic Science / Preclinical (10%).
Research Type | Count | % of Total |
|---|---|---|
Research summaries | 89 |
Data assembled from 3 of 12 sources · Last updated Sep 20, 2026, 10:51 AM UTC
European rare disease database
Genetic and Rare Diseases Info Center
Patient case studies | 14 | 10% |
Laboratory research | 13 | 10% |
Disease patterns and progression | 13 | 10% |
Testing and diagnosis research | 3 | 2% |
Clinical study results | 3 | 2% |
New treatment approaches | 1 | 1% |
Khoo SE (2026). [PMID: 41102056](https://pubmed.ncbi.nlm.nih.gov/41102056/). *Int J Oral Maxillofac Surg*. [Basic Science / Preclinical]
Gąsiorowska J (2026). [PMID: 42023627](https://pubmed.ncbi.nlm.nih.gov/42023627/). *Pediatr Endocrinol Diabetes Metab*. [Review / Meta-Analysis]
Papazachariou A (2026). [PMID: 41128447](https://pubmed.ncbi.nlm.nih.gov/41128447/). *Current opinion in clinical nutrition and metabolic care*. [Review / Meta-Analysis]
Lee S (2026). [PMID: 41206258](https://pubmed.ncbi.nlm.nih.gov/41206258/). *Am J Geriatr Psychiatry*. [Review / Meta-Analysis]
Huang Y (2026). [PMID: 41544799](https://pubmed.ncbi.nlm.nih.gov/41544799/). *Metabolism*. [Epidemiology / Natural History]
Amado C (2026). [PMID: 40975490](https://pubmed.ncbi.nlm.nih.gov/40975490/). *Ann Allergy Asthma Immunol*. [Review / Meta-Analysis]
David C (2026). [PMID: 41395910](https://pubmed.ncbi.nlm.nih.gov/41395910/). *Ann Rheum Dis*. [Epidemiology / Natural History]
Anderson EN (2026). [PMID: 41468891](https://pubmed.ncbi.nlm.nih.gov/41468891/). *Am J Hum Genet*. [Basic Science / Preclinical]
de Azevedo J (2025). [PMID: 41172437](https://pubmed.ncbi.nlm.nih.gov/41172437/). *Einstein (Sao Paulo)*. [Case Report / Case Series]
Gobble MRS (2025). [PMID: 40128490](https://pubmed.ncbi.nlm.nih.gov/40128490/). *Curr Diab Rep*. [Review / Meta-Analysis]